Newsletter
Careers
News
Contact
LinkedIn
Twitter
facebook
fr
Solutions
Services
Antigen Presentation
NEOEPITOPE DIRECT™
Bioanalytical Solutions
Clinical Biomarkers
PK Assays
Receptor Occupancy Assays
Bioinformatics and Datamining
Bioinformatics and Biostatistics
Antigen Atlas
TM
Database
CellEngine
TM
Software
Biologics Characterization – CMC
HCP Analysis
Biomarkers Development and Validation Services
Cell-Based Immune Profiling
Basophil Activation Test (BAT)
Cell Enumeration
Cellular Phenotyping
Cellular Proliferation and Cell Cycling
Fluorescence-Activated Cell Sorting (FACS)
Intracellular Cytokine Staining (ICS)
MDSC Assays
Pathway Mapping
Receptor Occupancy (RO) Assays
Surface Profiling
Clinical Lab Services
Clinical Laboratory Services
Quality Management Systems
Clinical Proteomics
B-cell Maturation Antigen (BCMA)
Clinically Relevant Biomarkers in FFPE
COVID-19 Clinical Testing for Drug Development
Diagnostic Tests (Belgium)
Genomics
All Genomic Services
Antisense Oligonucleotide (ASO) Drug Development
Digital PCR (dPCR)
Quantitative PCR
Histopathology
All Histopathology Services
IHC-IF
ISH
MOSAIC Laboratories – A CellCarta Company
Pathology Team
Digital Pathology and Image Analysis
Immunoassays
Immunogenicity Assessment
Mass Spectrometry-based Biomarker Services
Support Services for Clinical Studies
Clinical Site Training
Sample Management & Logistics
Sample Procurement
Technologies
ELISA
ELISpot and FluoroSpot
Olink® PEA Technology
Mass Cytometry (CyTOF)
Mass Spectrometry
MSD®
Multiparametric Flow Cytometry
Nanostring
TM
Therapeutic Areas
Oncology
Infectious Diseases
Immunology
Neurosciences
Phases
Discovery Phase
Preclinical Phase
Clinical Phase
Biologic Manufacturing
Science Hub
Brochures
Case Studies
CellTalk
Infographics
Insight from our experts
Posters
Press Releases
Scientific Publications
Videos
Web News
Webinars
White Papers
Events
About us
Services
Antigen Presentation
NEOEPITOPE DIRECT™
Bioanalytical Solutions
Clinical Biomarkers
PK Assays
Receptor Occupancy Assays
Bioinformatics and Datamining
Bioinformatics and Biostatistics
Antigen Atlas
TM
Database
CellEngine
TM
Software
Biologics Characterization – CMC
HCP Analysis
Biomarkers Development and Validation Services
Cell-Based Immune Profiling
Basophil Activation Test (BAT)
Cell Enumeration
Cellular Phenotyping
Cellular Proliferation and Cell Cycling
Fluorescence-Activated Cell Sorting (FACS)
Intracellular Cytokine Staining (ICS)
MDSC Assays
Pathway Mapping
Receptor Occupancy (RO) Assays
Surface Profiling
Clinical Lab Services
Clinical Laboratory Services
Quality Management Systems
Clinical Proteomics
B-cell Maturation Antigen (BCMA)
Clinically Relevant Biomarkers in FFPE
COVID-19 Clinical Testing for Drug Development
Diagnostic Tests (Belgium)
Genomics
All Genomic Services
Antisense Oligonucleotide (ASO) Drug Development
Digital PCR (dPCR)
Quantitative PCR
Histopathology
All Histopathology Services
IHC-IF
ISH
MOSAIC Laboratories – A CellCarta Company
Pathology Team
Digital Pathology and Image Analysis
Immunoassays
Immunogenicity Assessment
Mass Spectrometry-based Biomarker Services
Support Services for Clinical Studies
Clinical Site Training
Sample Management & Logistics
Sample Procurement
Technologies
ELISA
ELISpot and FluoroSpot
Olink® PEA Technology
Mass Cytometry (CyTOF)
Mass Spectrometry
MSD®
Multiparametric Flow Cytometry
Nanostring
TM
Therapeutic Areas
Oncology
Infectious Diseases
Immunology
Neurosciences
Phases
Discovery Phase
Preclinical Phase
Clinical Phase
Biologic Manufacturing
Phase
CellCarta Services - From Discovery to
all Phases of Clinical Development
Home
>
Phase
>
Clinical Phase
CellCarta offers a variety of services for every phase of drug development:
discovery, preclinical, clinical (Phase 0 to III), diagnostics and companion diagnostics (CDx).